Drug intelligence / Profile preview

Qinggan Jieyu Fang

Development stage: Unknown
Administration: Oral

Overview

Qinggan Jieyu Fang (清肝解郁方) is a traditional Chinese herbal formula used primarily for the treatment of conditions associated with liver qi stagnation and heat, such as migraine and related syndromes. It is composed of multiple herbs designed to "clear the liver" and "relieve depression" according to Traditional Chinese Medicine (TCM) theory. Clinical studies have evaluated its efficacy in reducing migraine symptoms, improving syndrome scores related to liver qi stagnation with heat, and enhancing quality of life measures compared to standard treatments[1]. The mechanism of action is based on TCM principles rather than a single molecular target; it likely involves modulation of neurotransmitter systems, anti-inflammatory effects, and regulation of vascular function.

Brand names: Qingganjieyu
Other names: 清肝解郁方

Targets

P2RX7 (P2X purinoceptor 7)

Beyond the preview

Go deeper on Qinggan Jieyu Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinggan Jieyu Fang.

Explore the full profile